H.C. Wainwright Reaffirms Buy Rating on Assembly Biosciences, Inc. (ASMB) Amid Promising Trial Data
Assembly Biosciences, Inc. (NASDAQ:ASMB) is one of the top long-term biotechnology stocks to buy. On October 14, H.C.
Assembly Biosciences Inc. (ASMB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 1,604,590 | $44,094,133 | +31% | 0.2% |
| 2. | Paradigm Biocapital Advisors Senai Asefaw | 1,553,748 | $42,696,995 | +134% | 0.8% |
| 3. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,415,000 | $38,884,200 | +42% | 2.32% |
| 4. | RA Capital Management Peter Kolchinsky | 1,020,410 | $28,040,867 | 0.24% | |
| 5. | Parkman Healthcare Partners Greg Martinez | 721,181 | $19,818,054 | +76% | 2.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 2,295,920 | $0.00 | 4,505,391 | 2025-08-08 | Filing | |
| $15.61 | 3,202 | $49,997.63 | 3,202 | 2024-12-30 | Filing | |
| $21.37 | 940,499 | $20,098,463.63 | 2,209,471 | 2024-12-19 | Filing | |
| $14.85 | 5,000 | $74,250.00 | 728,113 | 2024-11-25 | Filing | |
| $15.00 | 2,976 | $44,640.00 | 723,113 | 2024-11-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.35 | 9 | $183.13 | 17,673 | 2026-11-02 | Filing | |
| $19.61 | 718 | $14,078.33 | 17,682 | 2026-11-02 | Filing | |
| $20.35 | 29 | $590.09 | 59,257 | 2026-11-02 | Filing | |
| $19.61 | 2,564 | $50,274.14 | 59,286 | 2026-11-02 | Filing | |
| $20.35 | 29 | $590.09 | 53,800 | 2026-11-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 32,972 | $774,512 | 0% | |
| 2. | 5,578 | $131,028 | 0% | |
| 3. | 800 | $18,791 | 0% | |
| 4. | 480 | $11,275 | 0% | |
| 5. | 260 | $6,107 | 0% |
News See All
Top 8 Long-Term Biotechnology Stocks to Buy
In this article, we will examine the Top 8 Long-Term Biotechnology Stocks to Buy. Momentum in biotechnology stocks is accelerating after years of underperformance.
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial
Assembly Biosciences, Inc. (NASDAQ:ASMB) is one of the growth stocks that could double by 2027.
11 Growth Stocks That Could Double by 2027
In this article, we will take a detailed look at the 11 Growth Stocks That Could Double by 2027.
Assembly Biosciences, Inc. (ASMB) Announces Key Leadership and Plan Changes
Assembly Biosciences, Inc. (NASDAQ:ASMB) is among the best growth stocks to invest in for the next 5 years. In the wake of its recent Annual Meeting of Stockholders, Assembly Biosciences, Inc.
15 Best Growth Stocks to Invest in for the Next 5 Years
In this article, we will take a look at some of the best growth stocks to invest in for the next 5 years.
10 Best Small-Cap Biotech Stocks Under $10 in 2021
In this article we will list the 10 best small-cap biotech stocks under $10 in 2021. We like healthcare and technology industries because of their above-average long-term growth prospects.
Hedge Funds Are Selling Assembly Biosciences Inc (ASMB)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because...
Here's What Hedge Funds Think About Assembly Biosciences Inc (ASMB)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Is Assembly Biosciences Inc (ASMB) A Good Stock To Buy According To Hedge Funds?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively...